394 related articles for article (PubMed ID: 22894615)
1. β-lactamase-mediated resistance: a biochemical, epidemiological and genetic overview.
Gutkind GO; Di Conza J; Power P; Radice M
Curr Pharm Des; 2013; 19(2):164-208. PubMed ID: 22894615
[TBL] [Abstract][Full Text] [Related]
2. [Clinically important beta-lactamases of gram-negative bacteria: extended-spectrum beta-lactamases (ESBL)].
Hrabák J
Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):103-11. PubMed ID: 17900058
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
Susić E
Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687
[TBL] [Abstract][Full Text] [Related]
4. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens.
Pfeifer Y; Cullik A; Witte W
Int J Med Microbiol; 2010 Aug; 300(6):371-9. PubMed ID: 20537585
[TBL] [Abstract][Full Text] [Related]
5. Defining an extended-spectrum beta-lactamase.
Livermore DM
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():3-10. PubMed ID: 18154524
[TBL] [Abstract][Full Text] [Related]
6. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
Shah AA; Hasan F; Ahmed S; Hameed A
Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
[TBL] [Abstract][Full Text] [Related]
7. Extended-spectrum beta-lactamases.
Patterson JE
Semin Respir Infect; 2000 Dec; 15(4):299-307. PubMed ID: 11220412
[TBL] [Abstract][Full Text] [Related]
8. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat.
Bradford PA
Clin Microbiol Rev; 2001 Oct; 14(4):933-51, table of contents. PubMed ID: 11585791
[TBL] [Abstract][Full Text] [Related]
9. Treatment options for extended-spectrum beta-lactamase-producers.
Essack SY
FEMS Microbiol Lett; 2000 Sep; 190(2):181-4. PubMed ID: 11034276
[TBL] [Abstract][Full Text] [Related]
10. Minor extended-spectrum beta-lactamases.
Naas T; Poirel L; Nordmann P
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():42-52. PubMed ID: 18154527
[TBL] [Abstract][Full Text] [Related]
11. β-lactam resistance in gram-negative pathogens isolated from animals.
Trott D
Curr Pharm Des; 2013; 19(2):239-49. PubMed ID: 22894614
[TBL] [Abstract][Full Text] [Related]
12. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of infections caused by multiresistant gram-negatives: ESBLs, MBLs, panresistant strains.
Rossolini GM; Mantengoli E; Docquier JD; Musmanno RA; Coratza G
New Microbiol; 2007 Jul; 30(3):332-9. PubMed ID: 17802921
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria.
Bush K; Fisher JF
Annu Rev Microbiol; 2011; 65():455-78. PubMed ID: 21740228
[TBL] [Abstract][Full Text] [Related]
15. Dissemination of IncF plasmids carrying beta-lactamase genes in Gram-negative bacteria from Nigerian hospitals.
Ogbolu DO; Daini OA; Ogunledun A; Terry Alli OA; Webber MA
J Infect Dev Ctries; 2013 May; 7(5):382-90. PubMed ID: 23669427
[TBL] [Abstract][Full Text] [Related]
16. [Beta-lactamases in laboratory and their role in resistance Part I.: Evolution of bacterial resistance mediated by beta-lactamases].
Bedenić B
Lijec Vjesn; 2004; 126(11-12):314-24. PubMed ID: 16082890
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of β-lactamase production in Gram-negative bacteria from Saudi Arabia.
Yezli S; Shibl AM; Memish ZA
J Med Microbiol; 2015 Feb; 64(Pt 2):127-136. PubMed ID: 25418734
[TBL] [Abstract][Full Text] [Related]
18. SHV-type beta-lactamases.
Tzouvelekis LS; Bonomo RA
Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
[TBL] [Abstract][Full Text] [Related]
19. Extended-spectrum beta-lactamases: an actual problem of hospital microbiology (a review).
Szabó D; Barcs I; Rozgonyi F
Acta Microbiol Immunol Hung; 1997; 44(4):309-25. PubMed ID: 9554165
[TBL] [Abstract][Full Text] [Related]
20. Evolution and spread of SHV extended-spectrum beta-lactamases in gram-negative bacteria.
Heritage J; M'Zali FH; Gascoyne-Binzi D; Hawkey PM
J Antimicrob Chemother; 1999 Sep; 44(3):309-18. PubMed ID: 10511397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
